C88.30 — Immunoproliferative small intestinal disease not having achieved remission
C88.30 is a billable, specific ICD-10-CM code for immunoproliferative small intestinal disease not having achieved remission. It is valid for submission on a claim.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Alpha heavy chain disease NOS
- Alpha heavy chain disease not having achieved remission
- Alpha heavy chain disease with failed remission
- Immunoproliferative small intestinal disease NOS
- Immunoproliferative small intestinal disease with failed remission
- Mediterranean lymphoma NOS
- Mediterranean lymphoma not having achieved remission
- Mediterranean lymphoma with failed remission
Risk adjustment
C88.30 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C88.30 is named in 40 Medicare coverage policies — 40 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C88.3. If C88.30 is not quite right, the correct code is usually one of these.
Questions about C88.30
- Is C88.30 a billable ICD-10-CM code?
- Yes. C88.30 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C88.30 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).